S&P Biotechnology Select Industry Index ETF Overview

With 3 ETFs traded on the U.S. markets, S&P Biotechnology Select Industry Index ETFs have total assets under management of $7.49B. The average expense ratio is 0.81%. S&P Biotechnology Select Industry Index ETFs can be found in the following asset classes:

  • Equity

The largest S&P Biotechnology Select Industry Index ETF is the SPDR S&P Biotech ETF XBI with $6.72B in assets. In the last trailing year, the best-performing S&P Biotechnology Select Industry Index ETF was XBI at 3.52%. The most recent ETF launched in the S&P Biotechnology Select Industry Index space was the Direxion Daily S&P Biotech Bear 3X Shares LABD on 05/28/15.

ETF.com Analysis

ETFs All You Need For Portfolios

Building a core satellite ETF portfolio can give investors the best of two worlds.

Features and News

COVID Biotech ETFs Rise At Fever Pace

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

Daily ETF Watch

Cheapest Biotech & Semiconductor ETFs Launch

The new entrants come to market with category-low fees.

Features and News

Spiking Yields Pierce Bonds & Growth Stocks

Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.

Features and News

Sleeper Hit ETF Of 2020

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Daily ETF Watch

Junior Biotech ETF Debuts

New fund invests in small cap biotechnology stocks. 

Features and News

Hot & Cold Health Care ETF Returns

Health care ETFs have diverged sharply as some stocks benefit from the pursuit of virus treatments, others not so much.

ETF.com Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds.

Features and News

The Love & Hate Of Biotech ETFs

The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.